Consun Pharmaceutical Group Limited (HKG:1681)

HKG:1681 Revenue

In the year 2025, Consun Pharmaceutical Group had annual revenue of 3.42B CNY with 15.17% growth. Consun Pharmaceutical Group had revenue of 1.85B in the half year ending December 31, 2025, with 25.73% growth.

• Revenue: 3.42B CNY
• Revenue Growth: +15.17%
• P/S Ratio: 3.34
• Revenue / Employee: 1.11M CNY
• Employees: 3,073
• Market Cap: 12.71B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.42B	450.12M	15.17%
Dec 31, 2024	2.97B	377.12M	14.56%
Dec 31, 2023	2.59B	250.47M	10.71%
Dec 31, 2022	2.34B	294.99M	14.43%
Dec 31, 2021	2.04B	291.83M	16.65%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 12, 2026

Data Sources Report a data error